NCT06916754

Brief Summary

This clinical study is being conducted to compare the effectiveness of two psychological treatments for alcohol addiction: Combined Behavioral Intervention (CBI) and Ericksonian Hypnotherapy (EH). The purpose of the study is to determine whether Ericksonian Hypnotherapy, a more personalized and indirect therapeutic method, is equal to or more effective than the gold-standard approach, Combined Behavioral Intervention, in helping individuals reduce their alcohol consumption and improve psychological well-being. Alcohol addiction is a serious condition that affects mental, emotional, and physical health. Many treatment options exist, but not all individuals respond in the same way. This study aims to evaluate two different types of therapy in a structured way, to better understand which works best, for whom, and under what circumstances. The study will include 90 adult participants diagnosed with Alcohol Use Disorder (AUD). Participants will be randomly assigned to one of three groups: (1) a group receiving weekly sessions of Combined Behavioral Intervention, (2) a group receiving weekly sessions of Ericksonian Hypnotherapy, or (3) a control group receiving general educational materials about alcohol addiction. Treatment will last for 12 weeks, and all participants will be followed up three months after the last session to assess long-term effects. Throughout the study, researchers will measure changes in alcohol consumption, alcohol craving, mental health symptoms (such as depression and anxiety), quality of life, and motivation to change. The findings of this study may help improve the way alcohol addiction is treated by offering evidence on alternative approaches such as hypnotherapy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 1, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 8, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

April 16, 2025

Status Verified

April 1, 2025

Enrollment Period

9 months

First QC Date

April 1, 2025

Last Update Submit

April 13, 2025

Conditions

Keywords

Ericksonian HypnosisHypnotherapyCognitive Behavioral TherapyMotivational InterviewingRelapse PreventionCravingSubstance CravingPsychotherapy

Outcome Measures

Primary Outcomes (1)

  • Change in Alcohol Consumption (TLFB)

    Self-reported alcohol consumption measured using the Timeline Follow-Back (TLFB) method. TLFB assesses the number of standard drinks consumed each day over the past 30 days. Higher scores indicate greater alcohol use. A reduction in total drinks consumed per month represents clinical improvement.

    Baseline to Week 6, Week 12, and Month 10 (3-Month Follow-Up)

Secondary Outcomes (6)

  • Change in Craving Beliefs (CBQ)

    Baseline to Week 6, Week 12, and Week 24

  • Change in Craving Typologies (CTQ)

    Baseline to Week 6, Week 12, and Week 24

  • Change in Depression Symptoms (BDI-II)

    Baseline to Week 6, Week 12, and Week 24

  • Change in Anxiety Symptoms (BAI)

    Baseline to Week 6, Week 12, and Week 24

  • Change in Quality of Life (WHOQOL-BREF)

    Baseline to Week 6, Week 12, and Week 24

  • +1 more secondary outcomes

Study Arms (3)

Combined Behavioral Intervention (CBI)

EXPERIMENTAL

Participants in this arm will receive a manualized Combined Behavioral Intervention consisting of 12 weekly sessions, each approximately 60 minutes. The intervention includes elements of Motivational Interviewing, Cognitive Behavioral Therapy, and relapse prevention strategies. Sessions are delivered either individually by licensed therapists trained in behavioral therapy.

Behavioral: Combined Behavioral Intervention

Ericksonian Hypnotherapy (EH)

EXPERIMENTAL

Participants in this arm will receive Ericksonian Hypnotherapy in 12 weekly individual sessions, each approximately 45-60 minutes. The intervention uses personalized trance induction, metaphorical storytelling, ego-strengthening, and post-hypnotic suggestions.

Behavioral: Ericksonian Hypnotherapy

Control (Standard Care Information)

NO INTERVENTION

Participants in this group will not receive structured psychotherapy but will be provided with psychoeducational brochures and referral resources related to alcohol addiction treatment. They will complete the same assessment schedule as the other groups.

Interventions

The intervention includes 12 weekly sessions integrating Motivational Interviewing, Cognitive Behavioral Therapy, and relapse prevention strategies. Techniques include enhancing motivation to change, identifying cognitive distortions, managing high-risk situations, and developing alternative coping strategies.

Combined Behavioral Intervention (CBI)

This therapy includes 12 weekly sessions involving individualized trance induction, indirect suggestion, therapeutic metaphor, and ego-strengthening techniques. The sessions follow Ericksonian principles and are delivered by certified hypnotherapists.

Ericksonian Hypnotherapy (EH)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged between 18 and 65 years
  • Meets DSM-5 diagnostic criteria for Alcohol Use Disorder (mild to severe)
  • Medically and psychiatrically stable as determined by a clinician
  • Willing and able to participate in weekly sessions over a 12-week period
  • Provides informed consent

You may not qualify if:

  • Current diagnosis of a severe psychiatric disorder (e.g., psychotic disorder, bipolar I disorder)
  • Significant cognitive impairment that would interfere with treatment participation
  • Participation in another structured addiction treatment during the study period
  • Current use of psychotropic medications that may influence outcome measures (as assessed by the clinical team)
  • Unstable medical condition requiring immediate intervention
  • Pregnancy or planning to become pregnant during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beykoz University

Istanbul, 34820, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Alcohol-Related DisordersAlcoholismSubstance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Study Officials

  • Gökben Hızlı Sayar, Prof

    Üsküdar University

    STUDY CHAIR
  • Selami Varol Ülker, Phd

    Üsküdar University

    STUDY DIRECTOR
  • Metin Çınaroğlu, Phd

    Istanbul Nisantasi University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Metin Çınaroğlu, Phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors who collect follow-up and post-treatment data will be blinded to participants' group assignment. Participants and therapists are not blinded due to the nature of behavioral interventions.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Three-arm, parallel-group randomized controlled trial with equal allocation to Combined Behavioral Intervention (CBI), Ericksonian Hypnotherapy (EH), or control (standard care information). Each participant receives only one type of intervention throughout the 12-week treatment period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 1, 2025

First Posted

April 8, 2025

Study Start

March 1, 2025

Primary Completion

November 15, 2025

Study Completion

February 1, 2026

Last Updated

April 16, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) that underlie the results reported in published articles will be shared. This includes data on alcohol use, craving (CBQ and CTQ), depression, anxiety, quality of life, motivation to change, and session attendance. Data will be made available to qualified researchers affiliated with academic or nonprofit institutions upon request and approval. Data will be shared through secure institutional repositories.

Shared Documents
STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
Time Frame
Data will be available upon request starting immediately after the publication of the main study findings in a peer-reviewed journal. Data will remain accessible for 36 months after the date of publication.
Access Criteria
Access will be granted to qualified researchers affiliated with academic or non-profit institutions who provide a methodologically sound proposal approved by the study team. Requesters must sign a data use agreement. Access will include de-identified individual participant data and supporting documents. Requests can be submitted via email to the principal investigator following publication.

Locations